Home › Funds › ACT Capital Partners, L.P. › PALI
ACT Capital Partners, L.P. position in PALI
PALISADE BIO INC · Health Care
ACT Capital Partners, L.P. reported holding 307,500 shares of PALI (PALISADE BIO INC) in its Q3 2026 13F filing — a position valued at US$415K, representing 0.28% of its reported portfolio and ranking #36 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s PALI position evolved
ACT Capital Partners, L.P. first disclosed a stake in PALI in Q3 2026 at 307,500 shares (US$415K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 307.50K | $415.12K | New |
About PALI and 13F data
PALI (PALISADE BIO INC) is a Health Care company. 114 other funds we track also report a position in PALI — the largest reported positions include Soleus Capital Management, L.P. (US$27.3M), B Group, Inc. (US$23.9M), Octagon Capital Advisors LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PALI
- Soleus Capital Management, L.P. 13.06M sh · $27.30M · Q2 2026
- B Group, Inc. 11.41M sh · $23.86M · Q2 2026
- Octagon Capital Advisors LP 10.28M sh · $21.48M · Q2 2026
- Boxer Capital Management, LLC 4.80M sh · $10.03M · Q2 2026
- Squadron Capital Management LLC 3.00M sh · $6.27M · Q2 2026
- Propel Bio Management, LLC 2.58M sh · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.28M sh · $4.78M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 2.26M sh · $4.72M · Q2 2026
- HighVista Strategies LLC 2.03M sh · $4.24M · Q2 2026
- Artia Global Partners LP 1.99M sh · $4.16M · Q2 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 1.73M sh · $3.62M · Q2 2026
- Ally Bridge Group (NY) LLC 1.23M sh · $2.57M · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held PALI?
ACT Capital Partners, L.P. has disclosed PALI holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in PALI?
As of Q3 2026, ACT Capital Partners, L.P. holds 307.50K shares of PALI (PALISADE BIO INC), valued at $415.12K, representing 0.28% of its reported portfolio and ranking #36.
Has ACT Capital Partners, L.P. been buying or selling PALI?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in PALI.
Which other funds hold PALI?
Other major institutional holders of PALI include Soleus Capital Management, L.P., B Group, Inc., Octagon Capital Advisors LP, among 114 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.